SCHEMBL22058720

SCHEMBL22058720

O=[N+]([O-])c1ccc2c(c1)OC(O)(O)O2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.46
CA9 Q16790 2/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
AKR1B1 P15121 2/20 0.45
TSHR P16473 3/20 0.43
ALDH1A1 P00352 3/20 0.43
GPR35 Q9HC97 2/20 0.43
TP53 P04637 2/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
THRB P10828 1/20 0.42
CA12 O43570 1/20 0.41
TDP1 Q9NUW8 4/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP3A4 P08684 1/20 0.41
PTPRC P08575 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9424845 0.83 CYP1A2 (0.54) CA1CA9AKR1B1TSHRALDH1A1
SCHEMBL5311818 0.82 AKR1B1 (0.46) CA1CA9CA2CA7AKR1B1
SCHEMBL10920807 0.81 HSD17B10 (0.46) CA1CA9AKR1B1TSHRALDH1A1
SCHEMBL30849385 0.81 ALDH1A1 (0.43) CA1CA9AKR1B1TSHRALDH1A1
SCHEMBL9230962 0.81 ALDH1A1 (0.43) CA1CA9AKR1B1TSHRALDH1A1
SCHEMBL24179080 0.81 TSHR (0.42) CA1CA9CA2CA7AKR1B1
SCHEMBL30330229 0.81 ALDH1A1 (0.43) CA1CA9AKR1B1TSHRALDH1A1
SCHEMBL1168188 0.81 AKR1B1 (0.42) CA1CA9CA2CA7AKR1B1
SCHEMBL1168414 0.80 KMT2A (0.44) CA1CA9CA2CA7AKR1B1
SCHEMBL9427783 0.77 AKR1B1 (0.42) CA1CA9CA2CA7AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020112845-A1 PHARMACEUTICAL COMPOUNDS AND THERAPEUTIC METHODS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2020-06-04 WO disclosed